Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C4H8N2O3.H2O |
Molecular Weight | 150.1332 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.N[C@@H](CC(N)=O)C(O)=O
InChI
InChIKey=RBMGJIZCEWRQES-DKWTVANSSA-N
InChI=1S/C4H8N2O3.H2O/c5-2(4(8)9)1-3(6)7;/h2H,1,5H2,(H2,6,7)(H,8,9);1H2/t2-;/m0./s1
Molecular Formula | C4H8N2O3 |
Molecular Weight | 132.1179 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Asparagine is a non-essential amino acid, which is synthesized in the human body from L-aspartate by Asparagine synthetase. Asparagine is required for the synthesis of many important cellular proteins in normal human cells. Many tumor cells do not have this capacity, due to a lack of the enzyme L-asparagine synthetase, and therefore require an exogenous supply of the amino acid. This amino acid participates in the functions of the brain and nervous system. Asparagine may come from food or be taken as a dietary supplement.
Approval Year
Sample Use Guides
500 mg or 1 capsule daily as a dietary supplement or as recommended by a healthcare practitioner.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27126896
HeLa cells were treated with 0.1 mM asparagine and at this concentration, the amino acid promoted cancer cell proliferation in 3 times.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:07:37 GMT 2023
by
admin
on
Fri Dec 15 15:07:37 GMT 2023
|
Record UNII |
2PD79VF521
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1666924
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID90973512
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
C1505
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
CONCEPT | Dietary Supplement | ||
|
170358
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
1043513
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
C87433
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
100000153357
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
2PD79VF521
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
2PD79VF521
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
5794-13-8
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
SUB26049
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY | |||
|
SUB127325
Created by
admin on Fri Dec 15 15:07:37 GMT 2023 , Edited by admin on Fri Dec 15 15:07:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE | |||
|
PARENT -> SALT/SOLVATE |